ÂÜÀòÂÒÂ×

Amy Bachrodt serves as the Senior Vice President of Finance at Maze Therapeutics since May 2020, leading teams in Accounting, FP&A, Procurement, Facilities, and IT. Bachrodt also holds the position of AFBO Board Member at The Association of Bioscience Financial Officers International since October 2022. Previous experience includes roles such as Senior Director at Myovant Sciences, where FP&A and Treasury functions were established and led, and various leadership positions at Genentech, including Associate Director, Revenue Analytics, where a team of 11 focused on forecasting revenue impacts from healthcare trends. Earlier in the career, Bachrodt held managerial roles at Alvarez and Marsal and EY, contributing to complex dispute resolutions and forensic analysis. Academic credentials include an MSA in Accounting from the University of Notre Dame and a BA in Economics from Denison University.